Julia Vaübel

16.0k total citations
11 papers, 311 citations indexed

About

Julia Vaübel is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Julia Vaübel has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Julia Vaübel's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Melanoma and MAPK Pathways (5 papers). Julia Vaübel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Melanoma and MAPK Pathways (5 papers). Julia Vaübel collaborates with scholars based in Germany. Julia Vaübel's co-authors include Lisa Zimmer, Dirk Schadendorf, Elisabeth Livingstone, Axel Hauschild, Jan C. Simon, Claus Garbe, Klaus Griewank, Peter Mohr, Eckhart Kämpgen and Alexander Enk and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Julia Vaübel

9 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Vaübel Germany 6 195 140 137 125 28 11 311
Pui Ying Chan United Kingdom 6 124 0.6× 72 0.5× 64 0.5× 67 0.5× 69 2.5× 12 283
Meri‐Sisko Vuoristo Finland 7 173 0.9× 11 0.1× 57 0.4× 167 1.3× 22 0.8× 13 307
Sonia Leonardelli Germany 7 161 0.8× 72 0.5× 84 0.6× 79 0.6× 50 1.8× 9 246
Karen Jung Canada 12 106 0.5× 12 0.1× 42 0.3× 220 1.8× 19 0.7× 19 334
Lucie Heinzerling Germany 8 146 0.7× 10 0.1× 51 0.4× 70 0.6× 52 1.9× 22 210
Kelsey W. Nassar United States 5 170 0.9× 7 0.1× 84 0.6× 164 1.3× 36 1.3× 6 284
Kristina Buder‐Bakhaya Germany 7 256 1.3× 7 0.1× 106 0.8× 77 0.6× 50 1.8× 10 320
Andrée Rorive Belgium 12 197 1.0× 13 0.1× 32 0.2× 114 0.9× 107 3.8× 49 344
Robert J. Van Gulick United States 9 122 0.6× 5 0.0× 68 0.5× 129 1.0× 24 0.9× 14 242
Joseph Ibrahim United States 4 228 1.2× 4 0.0× 100 0.7× 152 1.2× 29 1.0× 7 303

Countries citing papers authored by Julia Vaübel

Since Specialization
Citations

This map shows the geographic impact of Julia Vaübel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Vaübel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Vaübel more than expected).

Fields of papers citing papers by Julia Vaübel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Vaübel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Vaübel. The network helps show where Julia Vaübel may publish in the future.

Co-authorship network of co-authors of Julia Vaübel

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Vaübel. A scholar is included among the top collaborators of Julia Vaübel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Vaübel. Julia Vaübel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zimmer, Lisa, Julia Vaübel, Peter Mohr, et al.. (2015). Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma. PLoS ONE. 10(3). e0118564–e0118564. 181 indexed citations
2.
Livingstone, Elisabeth, Lisa Zimmer, Julia Vaübel, & Dirk Schadendorf. (2014). BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management.. PubMed. 3(3). 29–29. 54 indexed citations
3.
Vaübel, Julia, Elisabeth Livingstone, Dirk Schadendorf, & Lisa Zimmer. (2014). Retarded low‐dose doxycycline for EGFR or MEK inhibitor–induced papulopustular rash. Journal of the European Academy of Dermatology and Venereology. 28(12). 1685–1689. 8 indexed citations
4.
Schadendorf, Dirk, Julia Vaübel, Elisabeth Livingstone, & Lisa Zimmer. (2012). Advances and perspectives in immunotherapy of melanoma. Annals of Oncology. 23. x104–x108. 15 indexed citations
5.
Zimmer, Lisa, Julia Vaübel, & Dirk Schadendorf. (2012). Immuntherapie des Melanoms. Der Hautarzt. 63(12). 952–960.
6.
Livingstone, Elisabeth, Lisa Zimmer, Julia Vaübel, & Dirk Schadendorf. (2012). Current advances and perspectives in the treatment of advanced melanoma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(5). 319–325. 14 indexed citations
7.
Zimmer, Lisa, Julia Vaübel, Elisabeth Livingstone, & Dirk Schadendorf. (2012). Side effects of systemic oncological therapies in dermatology. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(7). 475–486. 32 indexed citations
8.
Zimmer, Lisa, Julia Vaübel, Elisabeth Livingstone, & Dirk Schadendorf. (2012). Nebenwirkungen onkologischer Systemtherapien in der Dermatologie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(7). 475–487. 5 indexed citations
9.
Livingstone, Elisabeth, Lisa Zimmer, Julia Vaübel, & Dirk Schadendorf. (2012). Aktuelle Fortschritte und Ausblicke in der Therapie des metastasierten Melanoms. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(5). 319–325. 1 indexed citations
10.
Zimmer, Lisa, Julia Vaübel, & Dirk Schadendorf. (2012). Immuntherapie des Melanoms. Der Onkologe. 18(9). 801–807.
11.
Schilling, Bastian, Julia Vaübel, & Dirk Schadendorf. (2010). Adjuvant pegylated interferon α-2b therapy for melanoma. Oncology Letters. 1(2). 237–241. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pui Ying Chan Breakdown of academic impact, for papers by Meri‐Sisko Vuoristo Breakdown of academic impact, for papers by Sonia Leonardelli Breakdown of academic impact, for papers by Karen Jung Breakdown of academic impact, for papers by Lucie Heinzerling Breakdown of academic impact, for papers by Kelsey W. Nassar Breakdown of academic impact, for papers by Kristina Buder‐Bakhaya Breakdown of academic impact, for papers by Andrée Rorive Breakdown of academic impact, for papers by Robert J. Van Gulick Breakdown of academic impact, for papers by Joseph Ibrahim
Rankless by CCL
2026